ID: ALA464796

Max Phase: Preclinical

Molecular Formula: C17H24O2

Molecular Weight: 260.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CC(O)C#CC#CC(O)/C=C\CCCCCCC

Standard InChI:  InChI=1S/C17H24O2/c1-3-5-6-7-8-9-10-14-17(19)15-12-11-13-16(18)4-2/h4,10,14,16-19H,2-3,5-9H2,1H3/b14-10-

Standard InChI Key:  QWCNQXNAFCBLLV-UVTDQMKNSA-N

Associated Targets(Human)

ABCG2 Tchem ATP-binding cassette sub-family G member 2 (4927 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 260.38Molecular Weight (Monoisotopic): 260.1776AlogP: 2.82#Rotatable Bonds: 8
Polar Surface Area: 40.46Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.03CX Basic pKa: CX LogP: 4.38CX LogD: 4.38
Aromatic Rings: 0Heavy Atoms: 19QED Weighted: 0.40Np Likeness Score: 2.39

References

1. Moinul M, Amin SA, Jha T, Gayen S..  (2022)  Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development.,  241  [PMID:35944339] [10.1016/j.ejmech.2022.114628]

Source